Company: STAA
Filing Date: 2025-09-29
Form Type: DFAN14A
Source: 0001213900-25-093211
Chunk: 16

Company: STAAR SURGICAL CO
Filing Date: 2025-09-29
Form: DFAN14A
Chunk 16
---
 a key competitor before its technology can disrupt the market.

Whether shareholders agree, and whether regulators take an interest, could determine not just STAAR’s future but the future of competition in the refractive surgery space. With the window-shop period open until September 19, the clock is ticking for rival suitors to emerge and for STAAR’s board to prove it ran a fair process.

<div align='center'>6</div>

Exhibit 4

STAAR shareholder Broadwood says it opposes Alcon’s proposed takeover

By Maria Rugamer

September 2, 2025 2:14PM EDT ‧ Updated
September 2, 2025

Sept 2 (Reuters) - Broadwood Partners, the largest shareholder in medical
technology company STAAR Surgical (STAA.O), opens new tab, intends to vote against Alcon’s (ALCC.S), opens new tab proposed
acquisition of the company, it said on Tuesday.

Broadwood said that the Swiss eye care group’s offer did not
reflect STAAR’s recent financial improvements.

Alcon said in early August that the boards of both companies had approved
its offer of $28 per STAAR share, valuing the business at $1.5 billion.

Investment firm Broadwood, which holds a 27.5% stake in U.S.-based
STAAR, said it was disappointed with STAAR’s board for choosing to sell the company “without pursuing an adequate sale process”.
It urged the company to reconsider its recommendation of the offer.

STARR said last month that the transaction was anticipated to close
in approximately six to 12 months, subject to regulatory approval and approval by STAAR’s shareholders.

STAAR and Alcon did not immediately respond to requests for comment.

Broadwood also raised concerns over the timing of the proposed deal
in relation to an upcoming clinical trial publication.

According to Broadwood, the trial compares Alcon’s Lasik technology
with STAAR’s Evo ICL lenses, a competing product.

“STAAR and its shareholders have long seen the opportunity for
a further market share shift away from LASIK,” it said in a press release.

Reporting by Maria Rugamer in Gdansk, editing by Milla Nissi-Prussak
and Matt Scuffham

Exhibit 5

Alcon faces opposition from Staar Surgical’s largest shareholder in planned acquisition

September 2, 2025 By Sean Whooley

Broadwood Partners said today that it intends to vote against the proposed